Jump to:Page Content
Stand out from the crowd! Advertise in Trial to reach a national audience of major decision-makers who are looking for products and services to improve their legal practices.
Steven M. Sellers
A federal district court in Kentucky held that the Supreme Court’s decision in Pliva v. Mensing has at least one procedural limit—its preemption defense doesn’t apply to a claim that a defendant in a generic drug labeling case was fraudulently joined to defeat the court’s diversity jurisdiction. In Mensing, the Court held that the federal Food, Drug, and Cosmetic Act preempts state law failure-to-warn claims against generic prescription drug manufacturers, but the Court did not decide whether the preemption defense extended to drug distributors and joinder issues.